Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$191.51 - $216.16 $1.02 Million - $1.15 Million
-5,309 Reduced 49.81%
5,350 $1.14 Million
Q2 2023

Jul 26, 2023

SELL
$187.64 - $206.25 $1.07 Million - $1.18 Million
-5,716 Reduced 34.91%
10,659 $2.05 Million
Q1 2023

Apr 28, 2023

BUY
$127.59 - $203.08 $27,049 - $43,052
212 Added 1.31%
16,375 $3.32 Million
Q4 2022

Feb 01, 2023

BUY
$117.37 - $139.17 $1,760 - $2,087
15 Added 0.09%
16,163 $2.08 Million
Q3 2022

Oct 25, 2022

SELL
$135.27 - $180.11 $64,929 - $86,452
-480 Reduced 2.89%
16,148 $2.21 Million
Q2 2022

Aug 03, 2022

BUY
$108.81 - $179.33 $236,335 - $389,504
2,172 Added 15.02%
16,628 $2.95 Million
Q1 2022

May 04, 2022

BUY
$119.61 - $157.85 $127,623 - $168,425
1,067 Added 7.97%
14,456 $2.08 Million
Q4 2021

Jan 27, 2022

BUY
$142.57 - $190.86 $104,361 - $139,709
732 Added 5.78%
13,389 $2.07 Million
Q3 2021

Oct 29, 2021

BUY
$142.45 - $169.82 $242,734 - $289,373
1,704 Added 15.56%
12,657 $2.15 Million
Q2 2021

Jul 26, 2021

SELL
$135.08 - $161.1 $573,684 - $684,191
-4,247 Reduced 27.94%
10,953 $1.73 Million
Q1 2021

Apr 27, 2021

SELL
$137.51 - $190.8 $224,691 - $311,767
-1,634 Reduced 9.71%
15,200 $2.11 Million
Q4 2020

Jan 25, 2021

BUY
$164.63 - $211.93 $2.77 Million - $3.57 Million
16,834 New
16,834 $2.95 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.